参考文献/References:
[1] Hindricks G, Potpara T, Dagres N, et al. Corrigendum to: 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association of Cardio-Thoracic surgery(EACTS)[J]. Eur Heart J, 2021, 42(5): 546-547.
[2] Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge[J]. Int J Stroke, 2021, 16(2): 217-221.
[3] Du X, Guo L, Xia S, et al. Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China[J]. Heart(British Cardiac Society), 2021, 107(7):heartjnl-2020-317915.
[4] Kokkinidis DG, Zareifopoulos N, Theochari CA, et al. Association between atrial fibrillation and cognitive impairment in individuals with prior stroke: a Meta-Analysis and Meta-Regression analysis[J]. Stroke, 2020, 51(6): 1662-1666.
[5] Nishtala A, Piers RJ, Himali JJ, et al. Atrial fibrillation and cognitive decline in the Framingham Heart Study[J]. Heart Rhythm, 2018, 15(2): 166-172.
[6] Liu DS, Jing C, Jian WM, et al. The association of atrial fibrillation and dementia incidence: a meta-analysis of prospective cohort studies[J]. Journal of Geriatric Cardiology, 2019, 16(3): 298-306.
[7] Kim D, Yang PS, Yu HT, et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort[J]. Eur Heart J, 2019, 40(28): 2313-2323.
[8] Zhang J, Liu Y, Zheng Y, et al. TREM-2-p38 MAPK signaling regulates neuroinflammation during chronic cerebral hypoperfusion combined with diabetes mellitus[J]. J Neuroinflammation, 2020, 17(1): 2.
[9] Alosco ML, Spitznagel MB, Sweet LH, et al. Atrial fibrillation exacerbates cognitive dysfunction and cerebral perfusion in heart failure[J]. Pacing Clin Electrophysiol, 2015, 38(2): 178-186.
[10] Gardarsdottir M, Sigurdsson S, Aspelund T, et al. Improved brain perfusion after electrical cardioversion of atrial fibrillation[J]. Europace, 2020, 22(4): 530-537.
[11] Jin MN, Kim TH, Kang KW, et al. Atrial fibrillation catheter ablation improves 1-Year Follow-Up cognitive function, especially in patients with impaired cognitive function[J]. Circ Arrhythm Electrophysiol, 2019, 12(7): e007197.
[12] Kirchhof P, Camm AJ, Goette A, et al. Early Rhythm-Control therapy in patients with atrial fibrillation[J]. N Engl J Med, 2020, 383(14): 1305-1316.
[13] Stefansdottir H, Arnar DO, Aspelund T, et al. Atrial fibrillation is associated with reduced brain volume and cognitive function Independent of cerebral infarcts[J]. Stroke, 2013, 44(4): 1020-1025.
[14] Silva DS, Caseli BG, De Campos BM, et al. Cerebral structure and function in stroke-free patients with atrial fibrillation[J]. J Stroke Cerebrovasc Dis, 2021, 30(8): 105887.
[15] Knecht S, Oelschläger C, Duning T, et al. Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy[J]. Eur Heart J, 2008, 29(17): 2125-2132.
[16] Moazzami K, Shao IY, Chen LY, et al. Atrial fibrillation, brain volumes, and subclinical cerebrovascular disease(from the atherosclerosis risk in communities neurocognitive study [ARIC-NCS])[J]. Am J Cardiol, 2020, 125(2): 222-228.
[17] Graff-Radford J, Madhavan M, Vemuri PA, et al. Atrial fibrillation, cognitive impairment, and neuroimaging[J]. Alzheimers & Dementia, 2016, 12(4): 391-398.
[18] Rozov A, Rannap M, Lorenz F, et al. Processing of hippocampal network activity in the receiver network of the medial entorhinal cortex layer V[J]. J Neurosci, 2020, 40(44): 8413-8425.
[19] Qureshi A, Saed A, Tasneem N, et al. Neuroanatomical correlates of atrial fibrillation: a longitudinal MRI study[J]. J Vasc Interv Neurol, 2014, 7(5): 18-23.
[20] Tan AY, Zhou S, Ogawa M, et al. Neural mechanisms of paroxysmal atrial fibrillation and paroxysmal atrial tachycardia in ambulatory canines[J]. Circulation, 2008, 118(9): 916-925.
[21] Mejía-Mejía E, Budidha K, Abay TY, et al. Heart rate variability(HRV)and pulse rate variability(PRV)for the assessment of autonomic responses[J]. Front Physiol, 2020, 11(1): 779.
[22] Zeki AA, Haan MN, Deng Y, et al. Reduced heart rate variability is associated with worse cognitive performance in elderly Mexican Americans[J]. Alzheimers & Dementia, 2014, 63(1): 181-187.
[23] Hämmerle P, Aeschbacher S, Springer A, et al. Cardiac autonomic function and cognitive performance in patients with atrial fibrillation[J]. Clin Res Cardiol, 2022, 111(1): 60-69.
[24] Azeem F, Durrani R, Zerna C, et al. Silent brain infarctions and cognition decline: systematic review and meta-analysis[J]. J Neurol, 2020, 267(2): 502-512.
[25] Hämmerle P, Eick C, Poli S, et al. Association of heart rate variability with silent brain infarcts in patients with atrial fibrillation[J]. Front Cardiovasc Med, 2021, 8(3): 684461.
[26] Colivicchi F, Bassi A, Santini M, et al. Cardiac autonomic derangement and arrhythmias in right-sided stroke with insular involvement[J]. Stroke, 2004, 35(9): 2094-2098.
[27] Deng X, Hou J, Deng Q, et al. Association between the APOE gene polymorphism and lipid profile and the risk of atrial fibrillation[J]. Lipids Health Dis, 2021, 20(1): 123.
[28] Jung JH, Jeon S, Baik K, et al. Apolipoprotein E4, amyloid, and cognition in Alzheimer's and Lewy body disease[J]. Neurobiol Aging, 2021, 106(7): 45-54.
[29] Falsetti L, Viticchi G, Buratti L, et al. Interactions between Atrial Fibrillation, Cardiovascular Risk Factors, and ApoE Genotype in Promoting Cognitive Decline in Patients with Alzheimer's Disease: A Prospective Cohort Study[J]. J Alzheimers Dis, 2018, 62(2): 713-725.
[30] 苗海军,张雷,倪幼诗,等.老年心房颤动患者认知功能障碍的相关基因研究[J].中华老年医学杂志,2021,40(11):1343-1347.
[31] Akar JG, Jeske W, Wilber DJ. Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction[J]. J Am Coll Cardiol, 2008, 51(18): 1790-1793.
[32] Wu T, Chen L, Zhou L, et al. Platelets transport β-amyloid from the peripheral blood into the brain by destroying the blood-brain barrier to accelerate the process of Alzheimer's disease in mouse models[J]. Aging, 2021, 13(5): 7644-7659.
[33] Inyushin M, Zayas-Santiago A, Rojas L, et al. Platelet-generated amyloid beta peptides in Alzheimer's disease and glaucoma[J]. Histol Histopathol, 2019, 34(8): 843-856.
[34] Stellos K, Panagiota V, Kögel A, et al. Predictive value of platelet activation for the rate of cognitive decline in Alzheimer's disease patients[J]. J Cereb Blood Flow Metab, 2010, 30(11): 1817-1820.